Skip to main content
Equibles

ALPS ADVISORS INC

Position in ZTS — Zoetis Inc.

CIK 1376113 Denver, CO
Back to ZTS Full portfolio

Position in ZTS

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$2,138,266
-$945,478 QoQ
Shares Held
29,756
+14.1% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#472
of 1,414 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZTS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

ALPS ADVISORS INC holds $10,837,032 across 10 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (19.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BCRX
Biocryst Pharmaceuticals Inc
 317,960 $3,179,600
2 ZTS
Zoetis Inc.
This page 		29,756 $2,138,266
3 AMLX
Amylyx Pharmaceuticals, Inc.
 112,447 $2,019,548
4 RDY
Dr Reddys Laboratories Ltd
 54,068 $783,445
5 UTHR
UNITED THERAPEUTICS Corp
 1,405 $761,271
6 ANIP
Ani Pharmaceuticals Inc
 7,125 $589,807
7 COLL
Collegium Pharmaceutical, Inc
 14,552 $526,782
8 PAHC
Phibro Animal Health Corp
 10,131 $318,113

All Filings in ZTS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,138,266 29,756
2026-03-31 $3,083,744 26,087
2025-12-31 $3,334,481 26,502
2025-09-30 $3,890,502 26,589
2025-06-30 $3,825,297 24,529
2025-03-31 $4,044,297 24,563
2024-12-31 $3,910,971 24,004
2024-09-30 $4,704,359 24,078
2024-06-30 $3,274,423 18,888
2024-03-31 $3,199,761 18,910
2023-12-31 $3,652,134 18,504
2023-09-30 $3,221,761 18,518
2023-06-30 $2,440,904 14,174
2023-03-31 $2,161,722 12,988
2022-12-31 $2,053,605 14,013
2022-09-30 $2,361,665 15,926
2022-06-30 $2,711,908 15,777
2022-03-31 $288,731 1,531
2021-12-31 $1,458,323 5,976
2021-09-30 $2,916,176 15,021
2021-06-30 $2,919,888 15,668
2021-03-31 $2,464,718 15,651
2020-12-31 $2,834,683 17,128
2020-09-30 $2,989,392 18,077
2020-06-30 $2,615,407 19,085
2020-03-31 $2,359,802 20,051